| 1 |
Qi Y, Zhang Z, Li Y, Zhao G, Huang J, Zhang Y, Xue J, Tang X. Whether the Subacute MPTP-Treated Mouse is as Suitable as a Classic Model of Parkinsonism. Neuromolecular Med 2023. [PMID: 36913134 DOI: 10.1007/s12017-023-08740-7] [Reference Citation Analysis]
|
| 2 |
Rahimi S, Angaji SA, Majd A, Hatami B, Baghaei K. Evaluating the effect of basic fibroblast growth factor on the progression of NASH disease by inhibiting ceramide synthesis and ER stress-related pathways. Eur J Pharmacol 2023;942:175536. [PMID: 36693552 DOI: 10.1016/j.ejphar.2023.175536] [Reference Citation Analysis]
|
| 3 |
Huang W, Qiu W, Chen K, Ye S, Wang D, Hu J, Xu H, Lin L, Li X. Research progress of fibroblast growth factor in nervous system diseases. Zhejiang Da Xue Xue Bao Yi Xue Ban 2023;51:738-49. [PMID: 36915973 DOI: 10.3724/zdxbyxb-2022-0180] [Reference Citation Analysis]
|
| 4 |
Zhou F, Xie X, Zhang H, Liu T. Effect of antioxidant intake patterns on risks of dementia and cognitive decline. Eur Geriatr Med 2023;14:9-17. [PMID: 36445640 DOI: 10.1007/s41999-022-00720-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Ardizzone A, Bova V, Casili G, Filippone A, Campolo M, Lanza M, Esposito E, Paterniti I. SUN11602, a bFGF mimetic, modulated neuroinflammation, apoptosis and calcium-binding proteins in an in vivo model of MPTP-induced nigrostriatal degeneration. J Neuroinflammation 2022;19:107. [PMID: 35526035 DOI: 10.1186/s12974-022-02457-3] [Reference Citation Analysis]
|
| 6 |
Shahriari-Felordi M, Alikhani HK, Hashemian SR, Hassan M, Vosough M. Mini review ATF4 and GRP78 as novel molecular targets in ER-Stress modulation for critical COVID-19 patients. Mol Biol Rep 2022. [PMID: 35028855 DOI: 10.1007/s11033-021-07071-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Liu Y, Deng J, Liu Y, Li W, Nie X. FGF, Mechanism of Action, Role in Parkinson's Disease, and Therapeutics. Front Pharmacol 2021;12:675725. [PMID: 34234672 DOI: 10.3389/fphar.2021.675725] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 8 |
Lee B, Shin M, Park Y, Won SY, Cho KS. Physical Exercise-Induced Myokines in Neurodegenerative Diseases. Int J Mol Sci 2021;22:5795. [PMID: 34071457 DOI: 10.3390/ijms22115795] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 9 |
Zarate SM, Pandey G, Chilukuri S, Garcia JA, Cude B, Storey S, Salem NA, Bancroft EA, Hook M, Srinivasan R. Cytisine is neuroprotective in female but not male 6-hydroxydopamine lesioned parkinsonian mice and acts in combination with 17-β-estradiol to inhibit apoptotic endoplasmic reticulum stress in dopaminergic neurons. J Neurochem 2021;157:710-26. [PMID: 33354763 DOI: 10.1111/jnc.15282] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 10 |
Feng CW, Chen NF, Chan TF, Chen WF. Therapeutic Role of Protein Tyrosine Phosphatase 1B in Parkinson's Disease via Antineuroinflammation and Neuroprotection In Vitro and In Vivo. Parkinsons Dis 2020;2020:8814236. [PMID: 33456749 DOI: 10.1155/2020/8814236] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 11 |
Costa CAD, Manaa WE, Duplan E, Checler F. The Endoplasmic Reticulum Stress/Unfolded Protein Response and Their Contributions to Parkinson's Disease Physiopathology. Cells 2020;9:E2495. [PMID: 33212954 DOI: 10.3390/cells9112495] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 12 |
Peng T, Liu X, Wang J, Liu Y, Fu Z, Ma X, Li J, Sun G, Ji Y, Lu J, Wan W, Lu H. Fluoxetine-mediated inhibition of endoplasmic reticulum stress is involved in the neuroprotective effects of Parkinson's disease. Aging (Albany NY) 2018;10:4188-96. [PMID: 30585175 DOI: 10.18632/aging.101716] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 13 |
Enogieru AB, Omoruyi SI, Hiss DC, Ekpo OE. GRP78/BIP/HSPA5 as a Therapeutic Target in Models of Parkinson's Disease: A Mini Review. Adv Pharmacol Sci 2019;2019:2706783. [PMID: 30949202 DOI: 10.1155/2019/2706783] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 14 |
Zhang S, Wang J, Zhao H, Luo Y. Effects of three flavonoids from an ancient traditional Chinese medicine Radix puerariae on geriatric diseases. Brain Circ 2018;4:174-84. [PMID: 30693344 DOI: 10.4103/bc.bc_13_18] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 15 |
Tsai CW, Tsai RT, Liu SP, Chen CS, Tsai MC, Chien SH, Hung HS, Lin SZ, Shyu WC, Fu RH. Neuroprotective Effects of Betulin in Pharmacological and Transgenic Caenorhabditis elegans Models of Parkinson's Disease. Cell Transplant 2017;26:1903-18. [PMID: 29390878 DOI: 10.1177/0963689717738785] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 16 |
Bohush A, Niewiadomska G, Filipek A. Role of Mitogen Activated Protein Kinase Signaling in Parkinson's Disease. Int J Mol Sci 2018;19:E2973. [PMID: 30274251 DOI: 10.3390/ijms19102973] [Cited by in Crossref: 63] [Cited by in F6Publishing: 66] [Article Influence: 12.6] [Reference Citation Analysis]
|
| 17 |
Elmazoglu Z, Ergin V, Sahin E, Kayhan H, Karasu C. Oleuropein and rutin protect against 6-OHDA-induced neurotoxicity in PC12 cells through modulation of mitochondrial function and unfolded protein response. Interdiscip Toxicol 2017;10:129-41. [PMID: 30147420 DOI: 10.1515/intox-2017-0019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 18 |
Lan L, Tian FR, ZhuGe DL, ZhuGe QC, Shen BX, Jin BH, Huang JP, Wu MZ, Fan LX, Zhao YZ, Xu HL. Implantable porous gelatin microspheres sustained release of bFGF and improved its neuroprotective effect on rats after spinal cord injury. PLoS One 2017;12:e0173814. [PMID: 28291798 DOI: 10.1371/journal.pone.0173814] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
|
